Women’s fertility issues received a boost, as health start-up Yesmom announced the launch of Asia’s first at-home blood testing kits for female fertility, designed to help women stay on the front foot of their reproductive health from the comfort of home.
With a simple finger-prick, its new blood testing kit allows women to receive results on their reproductive health within a few days in an online dashboard that provides clear, comprehensive, clinical-grade insights.
Yesmom CEO Peter Macquart-Moulin said, “Women everywhere should have the option to be proactive about their reproductive healthcare.”
Moulin added: “While lab testing for fertility in Asia remains inaccessible to most consumers due to cost and confusing outcomes, we’ve developed an accessible, affordable at-home fertility testing kit that’s easy to use and provides quick results that are simple to understand.”
Building on four years of expertise in women’s health, Yesmom is becoming the go-to brand in Thailand in the ‘proactive health’ category, said the company.
Six fertility hormones
By examining the six fertility hormones Anti-Mullerian Hormone (AMH), Follicle Stimulating Hormone (FSH), Thyroid Stimulating Hormone (TSH), Free Thyroxine (ft4), Prolactin (PRL), and Testosterone (TT), Yesmom’s kit shows how hormone levels can affect egg freezing or IVF, screens for thyroid dysfunction that could negatively impact conception and flags anything that could affect normal ovulation and the fertility window.
Besides, it also enables women to learn more about menopause and make informed and timed decisions on their reproductive future.
It can indicate whether a woman may have Polycystic Ovary Syndrome (PCOS), a condition that affects up to 20% of women, often undiagnosed, and is a leading cause of infertility.
(With inputs from The OnLook News Research Bureau)